Showing results (51-60 of 108) with videos related to
Sort By:
Pageof 11
Journal of Gastroenterology and Hepatology|July 5, 2007
Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis CTakashi Honda, Yoshiaki Katano, Fumihiro Urano, et al.Journal of Viral Hepatitis|July 12, 2018
Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapyKazuhiko Hayashi, Masatoshi Ishigami, Yoji Ishizu, et al.Blood Cells, Molecules & Diseases|February 3, 2012
Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosisAi Hattori, Naohisa Tomosugi, Yasuaki Tatsumi, et al.Journal of Gastroenterology and Hepatology|January 16, 2010
Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strainsKazuhiko Hayashi, Yoshiaki Katano, Masatoshi Ishigami, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapyKazuhiko Hayashi, Yoshiaki Katano, Takashi Honda, et al.Journal of Gastroenterology and Hepatology|April 26, 2017
Comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon-free therapy in hepatitis C virus genotype 1bKazuhiko Hayashi, Masatoshi Ishigami, Yoji Ishizu, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of hepatitis B-related multiple hepatocellular carcinomas, most of which lead to necrosis possibly due to the implantation of an arterial infusion catheter]Teiji Kuzuya, Kinichi Takeda, Setsuo Utsunomiya, et al.European Journal of Pharmacology|December 28, 2013
Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cellsYuki Komori, Sakiko Arisawa, Miho Takai, et al.Anticancer Research|September 29, 2023
Clinical Outcomes With Lenvatinib in Patients Previously Treated With Atezolizumab/Bevacizumab for Advanced Hepatocellular CarcinomaHisanori Muto, Teiji Kuzuya, Naoto Kawabe, et al.Internal Medicine (Tokyo, Japan)|November 20, 2010
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosisHisao Hayashi, Alberto Piperno, Naohisa Tomosugi, et al.Pageof 11